Ekso Bionics Holdings, Inc.
EKSO
$0.4046
$0.02476.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -1.94% | 4.12% | 15.63% | 23.82% | 41.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.94% | 4.12% | 15.63% | 23.82% | 41.57% |
| Cost of Revenue | -8.54% | -0.92% | 8.16% | 19.04% | 37.35% |
| Gross Profit | 4.76% | 9.28% | 23.56% | 28.91% | 46.11% |
| SG&A Expenses | -15.37% | -16.56% | -16.71% | -5.25% | 5.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.99% | -11.25% | -7.37% | 5.29% | 17.29% |
| Operating Income | 30.78% | 27.46% | 28.84% | 11.71% | 2.85% |
| Income Before Tax | 25.45% | 26.59% | 22.84% | 4.11% | -0.78% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.45% | 26.59% | 22.84% | 4.11% | -0.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.45% | 26.59% | 22.84% | 4.11% | -0.78% |
| EBIT | 30.78% | 27.46% | 28.84% | 11.71% | 2.85% |
| EBITDA | 34.01% | 31.14% | 33.71% | 16.79% | 8.56% |
| EPS Basic | 48.27% | 41.65% | 34.68% | 14.43% | 5.41% |
| Normalized Basic EPS | 48.83% | 42.20% | 35.20% | 14.98% | 5.41% |
| EPS Diluted | 48.45% | 41.32% | 34.37% | 14.09% | 5.08% |
| Normalized Diluted EPS | 48.83% | 42.20% | 35.20% | 14.98% | 5.41% |
| Average Basic Shares Outstanding | 45.34% | 29.97% | 20.69% | 13.67% | 6.96% |
| Average Diluted Shares Outstanding | 45.34% | 29.97% | 20.69% | 13.67% | 6.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
